Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation.
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Carneiro M, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Monte-Mór B, Bonamino MH. Gomez Limia CE, et al. Stem Cell Res. 2017 Oct;24:16-20. doi: 10.1016/j.scr.2017.08.006. Epub 2017 Aug 8. Stem Cell Res. 2017. PMID: 29034885 Free article.
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
Secardin L, Limia CEG, di Stefano A, Bonamino MH, Saliba J, Kataoka K, Rehen SK, Raslova H, Marty C, Ogawa S, Vainchenker W, Monte-Mor BDCR, Plo I. Secardin L, et al. Among authors: monte mor bdcr. Stem Cell Res. 2020 Apr;44:101755. doi: 10.1016/j.scr.2020.101755. Epub 2020 Mar 6. Stem Cell Res. 2020. PMID: 32193150 Free article.
Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53.
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Bonamino MH, Monte-Mór B. Gomez Limia CE, et al. Among authors: monte mor b. Stem Cell Res. 2018 Dec;33:130-134. doi: 10.1016/j.scr.2018.09.012. Epub 2018 Sep 20. Stem Cell Res. 2018. PMID: 30343103 Free article.
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.
Secardin L, Gomez Limia C, da Silva-Benedito S, Lordier L, El-Khoury M, Marty C, Ianotto JC, Raslova H, Constantinescu SN, Bonamino MH, Vainchenker W, Monte-Mor B, Di Stefano A, Plo I. Secardin L, et al. Among authors: monte mor b. Hemasphere. 2021 Jun 12;5(7):e593. doi: 10.1097/HS9.0000000000000593. eCollection 2021 Jul. Hemasphere. 2021. PMID: 34131633 Free PMC article.
Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment.
Hasan S, Cassinat B, Droin N, Le Couedic JP, Favale F, Monte-Mor B, Lacout C, Fontenay M, Dosquet C, Chomienne C, Solary E, Villeval JL, Casadevall N, Kiladjian JJ, Vainchenker W, Plo I. Hasan S, et al. Leukemia. 2014 Feb;28(2):460-3. doi: 10.1038/leu.2013.303. Epub 2013 Oct 22. Leukemia. 2014. PMID: 24150219 No abstract available.
16 results